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I.  INTRODUCTION 
At a July 30, 1999 Congressional hearing, an investigative journalist testified that 
he was able to order Viagra for his cat, Tom, using the cat’s actual height and 
weight.2  In other instances, the reporter and a colleague were able to obtain Viagra 
for a ninety-eight year old man and a prescription diet drug for a seven-year-old girl.3  
In testimony before the same Congressional subcommittee, Dr. Janet Woodcock, the 
director of the Center for Drug Evaluation and Research at the U.S. Food and Drug 
Administration [hereinafter “FDA”] said FDA investigators have found websites 
offering kits for making homemade drugs, home abortion kits, and unapproved HIV 
home test kits.4  Woodcock complained of doctors who work with (or for) online 
pharmacies, sending prescriptions across the Internet on the basis of an electronic 
questionnaire.5  Woodcock said some of the physicians prescribe to anyone sight 
unseen – perhaps like “Tom” – without even requiring a questionnaire.6   
As Woodcock and her colleagues have learned, Internet pharmacies are a 
nightmare for regulators.  The unique qualities of e-commerce make it difficult to 
regulate under any circumstances, but the growth of online pharmacies in particular 
is far outpacing the ability of government officials to investigate and enforce existing 
                                                                
1J.D., Stanford Law School, 2001.  Clerk to The Honorable Morris S. Arnold, U.S. Court 
of Appeals, 8th Circuit. 
2Congressional Panel Discusses Online Pharmacies, 11 LOY. CONSUMER L. REV. 212 
(1999). 
3Id. 
4Janet Woodcock, Director, Center for Drug Evaluation and Research, U.S. Food and 
Drug Administration, Statement before the Subcommittee on Oversight and Investigations, 
U.S. House of Representatives (July 30, 1999). 
5Id. 
6Id. 
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drug laws.  In 1999, Americans spent an estimated $44 million purchasing 
prescription drugs from online pharmacies, a figure that is projected to reach $1 
billion per year by 2003.7  In December of 1999, President Clinton proposed $10 
million in new funding for the FDA to regulate Internet pharmacies and hire 100 new 
employees,8 but the FDA has yet to explain whether this would be enough to keep up 
with the rapid growth of online pharmacies.  Clinton also proposed raising civil fines 
as high as $500,000 for pharmacies and pharmacists who violate state and federal 
drug laws, and he proposed giving the FDA administrative subpoena authority.9  
Several members of Congress have proposed their own legislation,10 and last year 
Democrats on the House Commerce Committee asked the General Accounting 
Office to investigate online pharmacies.11  This paper will consider the current laws 
governing online pharmacies (to the limited extent the state of the law can be 
discerned), the practical limits of traditional regulation and enforcement, and 
possible legal and regulatory responses to online pharmacies. 
II.  THE NEW TELEMEDICINE 
“Telepharmacy” could have an enormous impact on the legal and regulatory 
boundaries of the overall field of telemedicine and perhaps electronic commerce in 
general.  Online pharmacies are a collision in progress between the free-wheeling 
atmosphere of the Internet and one of the most tightly regulated industries in the 
United States.  On December 28, 1999, when President Clinton proposed the new 
enforcement powers for the FDA, it marked the first major attempt by the federal or 
state governments to regulate electronic commerce other than child pornography.12  
Even at this early stage, online pharmacies are capable of raising Constitutional 
questions of state police powers versus federal regulation of interstate commerce.  
State and federal officials will be forced to reconsider what constitutes the practice of 
medicine and who should regulate it.  Legal and ethical questions for physicians – 
not just pharmacists – appear to be arising much more quickly in the context of 
telepharmacy than the traditional realm of telemedicine.13 
                                                                
7Phil Galewitz, Web Pharmacies Mull Regulations, ASSOCIATED PRESS ONLINE, Dec. 29, 
1999, at 1999 WL 28153972. 
8OFFICE OF THE PRESS SECRETARY, THE WHITE HOUSE, THE CLINTON ADMINISTRATION 
UNVEILS NEW INITIATIVE TO PROTECT CONSUMERS BUYING PRESCRIPTION DRUG PRODUCTS 
OVER THE INTERNET (1999); Robert Pear, Clinton to Encourage Congress to Regulate Online 
Pharmacies, N.Y. TIMES, Dec. 28, 1999 at A1. 
9Id. 
10Marilyn Werber Serafini, Drugs on the Web, NAT’L J., Nov. 3, 1999, available at 1999 
WL 28248187. 
11Letter from U.S. Congressman John D. Dingell to Hon. David M. Walker, U.S. 
Comptroller General (March 2, 1999), available at <http://www.house.gov/commerce_ 
democrats/press/ 106ltr16.htm>. 
12States Should Control Internet Drug Sales, S.F. CHRON., Jan. 3, 2000, available at 
<http://www.sfgate.com/cgi-bin/article.cgi?file=/chronicle/archive/2000/01/03/ 
ED59969.DTL>. 
13See, e.g., Sheryl Gay Stolberg, Virtual Druggists: Internet Prescriptions Boom in the 
‘Wild West’ of the Web, N.Y. TIMES, June 27, 1999, at A1; Center for Telemedicine Law, 
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Yet to some extent, the recent regulatory hoopla about Internet pharmacies can be 
misleading.  To be sure, online pharmacies raise plenty of novel legal questions, but 
many of the legal issues pertinent to online pharmacies have already been raised in 
analogous areas of practice, such as mail-order pharmacy and telemedicine.  What 
appears to have changed is the volume of activity and the practicality of 
enforcement:  the amount of prescription drugs intercepted by the U.S. Customs 
Service is a good indicator of the growth in sales.  “We’ve been deluged with 
prescription drugs coming in from overseas,” said U.S. Customs Service 
Commissioner Raymond Kelly in an interview with the New York Times.14  “It’s a 
major challenge to deal with this huge increase in volume.”15  In 1999, the Customs 
Service seized 9725 packages with prescription drugs, up from 2145 packages the 
year before.16  The number of pills and tablets impounded jumped from 760,720 in 
1998 to 1.9 million in 1999.17  And federal officials say the impounded drugs 
probably represent only a small fraction of what consumers import illegally.18 
Though regulators and academics have been trying to anticipate the impact of 
telemedicine for twenty years or more, the phenomenon of online pharmacies seems 
to have caught them off guard.  That is probably because commentators focused 
almost exclusively on “traditional” telemedicine, namely the role of practitioners 
who use telecommunications to consult with other practitioners or with patients.  
Issues of interstate health care delivery are not new, but the case law is not 
particularly well developed for the very reason that cases involving interstate 
medicine did not arise that often.  Many of the appellate cases, for example, dealt 
with choosing the correct state forum for a medical malpractice case.19  Regulatory 
concerns seem to have been an afterthought.  Even now, regulators and legislators 
are focusing far less attention on traditional telemedicine because it doesn’t seem to 
have been the source of any major public health problems.  By contrast, regulators 
fear online pharmacies in the United States and overseas pose a substantial threat to 
public health.20 
In 1998, after police in Illinois found a man lying unconscious in a hotel parking 
lot, FDA officials learned he had purchased a kit to make GHB (an illegal steroid 
                                                          
Online Prescriptions by Physicians Undergoing Increased Scrutiny (1999), at 
<http://www.ctl.org/html/alert07191999.htm> (citing several cases involving sanctions against 
doctors and pharmacists practicing on the Internet). 
14Robert Pear, Government Warning on Buying Pills Online: Overseas Bargains Probably 
Also Illegal, S.F. CHRON. Jan. 10, 2000, available at <http://www.sfgate.com/cgi-
bin/article.cgi?file=/chronicle/archive/2000/01/10/MN17567.DTL>. 
15Id.  
16Id. 
17Id. 
18Id. 
19See, e.g., Wright v. Yackley, 459 F.2d 287 (9th Cir. 1972); Kennedy v. Freeman, 919 
F.2d 126 (10th Cir. 1990); McGee v. Riekhof, 442 F. Supp. 1276 (D. Mont. 1978). 
20See, e.g., John Hinkel, Buying Drugs Online: It’s Convenient and Private, but Beware of 
‘Rogue Sites’, FDA CONSUMER (Jan.-Feb. 2000). 
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frequently used by bodybuilders) and overdosed on his homemade drugs.21  A fifty-
two year-old Illinois man with episodes of chest pain and a family history of heart 
disease died of a heart attack in March 1999 after buying Viagra from an online 
source, even though Viagra is not recommended for anyone with heart disease.22  
FDA officials say there is no proof linking the man’s death to the drug, but add the 
problems likely would have been discovered within the traditional doctor-patient 
relationship.23  In any event, FDA official Woodcock said the sheer volume of 
electronic drug sales forces FDA officials to rely on “triage” in deciding which cases 
to investigate.24 
States have also joined the fight against unregulated pharmacies.  The attorneys 
general of Kansas, Illinois, and Missouri sued out-of-state pharmacies and doctors 
who were operating online, and the courts in Kansas and Missouri have issued 
injunctions.25  Kansas Attorney General Carla J. Stovall sued seven companies, six 
doctors, four other individuals, and three out-of-state pharmacies after a state 
investigation uncovered online vendors willing to sell prescription drugs directly to 
minors.26  A minor, acting under the direction of one of the agents, was able to 
purchase Viagra and the diet-drug Meridia using his true age and his mother’s credit 
card.27  The companies did not require parental consent and required no examination 
or consultation with a physician.28   
Meanwhile, libertarians and even state governments have warned that the FDA 
may be trying to extend its regulatory reach too far.  One group, the “Life Extension 
Foundation,” assailed the FDA for citing the Illinois man who died of a heart attack:   
The FDA is using this one death as an example of why the FDA needs to 
impose dictatorial power over all health websites.  One problem with this 
position is that, as of November 1998, at least 130 Americans died from 
taking Viagra legally prescribed by their doctors….  The FDA failed to 
detect the lethal side effects of Viagra, yet it is now seeking gestapo-like 
                                                                
21Id. 
22Hinkel, supra note 20. 
23Id. 
24Id. 
25OFFICE OF THE ATTORNEY GENERAL OF KANSAS, ATTORNEY GENERAL FILES LAWSUITS TO 
PROHIBIT INTERNET DRUG SALES (June 9, 1999), available at 
<http://www.ink.org/public/ksag/contents/news-releases/news99/internetdrugsales.htm>; 
OFFICE OF THE ATTORNEY GENERAL OF ILLINOIS, RYAN SUES TO PROTECT CONSUMERS AGAINST 
ILLEGAL SALES OF PRESCRIPTION DRUGS OVER THE INTERNET (Oct. 21, 1999), available at 
<http://cait.wiu.edu/press/pressfrm.html>; OFFICE OF THE ATTORNEY GENERAL OF MISSOURI, 
NIXON OBTAINS INJUNCTION AGAINST TEXAS PHARMACY TO STOP ILLEGAL INTERNET DRUG 
SALES; RESTITUTION, PENALTIES ORDERED (Oct. 25, 1999), available at 
<http://cait.wiu.edu/press/pressfrm.html>. 
26OFFICE OF THE ATTORNEY GENERAL OF KANSAS, supra note 25. 
27Id.  
28Id. 
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power to attack any Internet health company it wishes to, without due 
process.29 
Representatives of state pharmacy boards have been considerably less strident in 
their criticism, but are nonetheless wary of a larger FDA role. 30  The National 
Assocation of Boards of Pharmacy, which represents the boards of pharmacy of all 
U.S. states and territories, and the District of Columbia, has created its own 
voluntary certification program and does not want the FDA trying to duplicate state 
functions.31 
III.  WHERE IS CYBERSPACE AND WHAT HAPPENED THERE? 
The allegations in the Kansas suit illustrate some of the jurisdictional questions 
facing not only pharmacy regulators, but Internet regulators generally.  For example, 
Attorney General Stovall claimed the defendants sold, and prescribed Viagra “in the 
state of Kansas.”32  But the defendant corporation was actually located in Nevada – 
so where did the actual sale take place?33  In Kansas, in Nevada, or in the nebulous 
realm of cyberspace?  Defining “prescribed” and “dispensed” are even more 
problematic for Stovall.  One could argue that the doctor does the prescribing – the 
patient only receives the prescription – and the doctor was not in Kansas.  Moreover, 
Stovall accused the defendant doctors of practicing medicine in Kansas without a 
license from Kansas medical authorities.34  But if the doctor had legal authority to 
prescribe in Nevada (leaving aside the issue of whether Nevada allows doctors to 
prescribe without an examination) and the prescription was filled in Nevada, then the 
question of whether he practiced medicine in Kansas becomes even more complex. 
Prior cases in interstate medicine do not really address these issues directly, but 
instead the state courts analyzed whether sufficient minimum contacts occurred 
between the patient and an out-of-state physician to justify in personam jurisdiction 
over the out-of-state physician.  Perhaps the most widely cited of these cases is 
Wright v. Yackley.35  While living in South Dakota, the plaintiff was treated by the 
defendant, a South Dakota doctor.36  The plaintiff later moved to Idaho and asked the 
South Dakota doctor to send a copy of her prescription to an Idaho pharmacy.37  The 
plaintiff alleged she was injured by the drugs and filed suit against the South Dakota 
                                                                
29Statement of William Faloon, Vice President, Life Extension Foundation, at 
<http://www.lef.org/magazine/mag2000/march00-awsi.html>. 
30Chris Adams, Plan to Curb Drugstores On Web Is Hit, WALL ST. J., Dec. 29, 1999, at 
A3. 
31Id. 
32Stoval v. Focus Med. Group, Inc., No. ___ (Shawnee County Dist. Ct. June 9, 1999). 
(unreported Kansas trial court opinion) (copy on file with the author). 
33Id.  
34Id.  
35459 F.2d 287. 
36Id. at 287. 
37Id.  
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doctor in Idaho court.38  The Ninth Circuit cited § 37 of the Restatement (Second) of 
Conflict of Laws (1971): 
A state has power to exercise judicial jurisdiction over an individual who 
causes effects in the state by an act done elsewhere with respect to any 
cause of action arising from these effects unless the nature of the effects 
and of the individual’s relationship to the state make the exercise of such 
jurisdiction unreasonable.39 
The court held that jurisdiction in Idaho would be unreasonable because the 
defendant was not one who “purposely avails itself of the privilege of conducting 
activities within the forum State.”40  However, the court left open the question of 
“diagnosis by mail”: 
The balance of factors involved in a due process determination might be 
different if a doctor could be said to have treated an out-of-state patient by 
mail or to have provided a new prescription or diagnosis in such fashion.  
In that event, the forum state’s interest in deterring such interstate medical 
service would surely be great.41 
The court foresaw, quite correctly, that subsequent jurisdictional analyses would 
necessarily be made on a case-by-case basis.42  But the court also concluded (albeit 
in dicta) that intentionally practicing across state lines would subject the practitioner 
to the jurisdiction of the patient’s home state.43 
Courts are fairly uniform in finding in personam jurisdiction over practitioners 
who deliberately practice across state lines.  This is clearly the issue most relevant to 
online practitioners, since they are intentionally creating a practice that will cross 
jurisdictional boundaries.  In McGee v. Riekhof, for example, the defendant was a 
Utah surgeon who had performed surgery on a Montana resident in Utah.44  The U.S. 
District Court upheld jurisdiction in Montana because the surgeon had, via 
telephone, provided a new diagnosis to the patient while the patient was in 
Montana.45  This raises an interesting question (one not addressed by the court), 
namely whether the Utah surgeon should have held a Montana license to consult 
with his patient there.  Could Montana medical officials bring charges against the 
Utah doctor for practicing in Montana?  If so, specialists who treat patients from 
around the country – and the world – would need a license in each of the fifty states 
in order to consult with a patient by phone.  One could argue that a court’s standard 
                                                                
38Id.  
39Id. at 289.  
40Wright, 459 F.2d at 290 (citing Hanson v. Denckla, 357 U.S. 235, 253 (1958)). 
41Id. at 289. 
42See Prince v. Urban, 49 Cal. App. 4th 1056 (1996) (providing an overview of the case 
law regarding in personam jurisdiction over out-of-state practitioners). 
43Wright, 459 F.2d at 289 n.4.  
44442 F. Supp. at 1277. 
45Id.  
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for in personam jurisdiction is different from the regulatory jurisdiction of a state 
medical board.  Even so, current case law will encourage states to continue asserting 
their jurisdiction aggressively (as the states seem to be doing) over out-of-state 
practitioners. 
IV.  WHO GETS TO REGULATE? 
Perhaps because of their wariness of the FDA, state boards of pharmacy have 
moved quickly to maintain their role in regulating online pharmacies.  Acting 
through the National Association of Boards of Pharmacy [hereinafter “NABP”], the 
states created the Verification of Internet Pharmacy Practice Sites program, or 
VIPPS, which will provide a NABP “seal of approval” to sites meeting the 
organization’s standards.46  To earn the seal, online pharmacies must be registered 
with the pharmacy boards of each of the fifty states and approved to operate in all the 
states. 47  To date, only four pharmacies have earned the NABP’s approval.48  In her 
July 30, 1999 testimony, Woodcock praised VIPPS – a voluntary partnership 
between pharmacies and state regulators – and said “government should encourage 
private sector leadership in achieving a safe marketplace.”49  Five months later, the 
FDA’s strategy apparently shifted to favor more federal regulation; the White House 
released a proposal on Dec. 28, 1999 to increase federal regulation of Internet 
pharmacies and to enhance civil penalties.50 
Current federal law, i.e. the Food, Drug and Cosmetic Act [hereinafter “FDC”],51 
certainly was not written with the Internet in mind.  When the first federal food and 
drug law was adopted near the turn of the century, pharmacies were the domain of 
local merchants, not unlike banks or grocery stores, and regulators were trying to get 
a handle on snake oil salesmen.  Snake oil salesmen were probably a lesser concern 
when the FDC was revised in 1970, but pharmacy still was primarily a local retail 
business.  (Based on Dr. Woodcock’s testimony, regulators now seem to be shifting 
their concern back to the snake oil salesmen…or saleswomen).  Though retail 
pharmacy has traditionally dominated the market, interstate pharmacy has been 
around for quite a while.  In fact, Congress made reference to mail-order pharmacy 
as early as 1951.52 
One might argue that mail-order pharmacies deal only with filling prescriptions 
written by a doctor after a traditional, face-to-face encounter with a patient, and 
therefore there are no similarities to the online “appointments” between patients and 
doctors hired by the online pharmacies.  However, Congress inserted a reference to 
“diagnosis by mail” in the 1951 amendment to the FDC.53  Interestingly, not a single 
                                                                
46Website of VIPPS, at <http://www.nabp.org/vipps/intro.asp>. 
47Id. 
48Id. 
49Woodcock, supra note 4. 
50OFFICE OF THE PRESS SECRETARY, supra note 8. 
5121 U.S.C. § 301, et seq. (1999). 
52See S. REP. NO. 82-946 (1951). 
53Id. 
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case or commentary on Westlaw makes reference to this brief passage in the FDC, 
even though many state and federal courts have grappled with the interstate practice 
of medicine.  The legislative history does not offer much detail either.  According to 
the committee report on the 1951 bill that amended the FDC, a representative of a 
mail-order company that delivered phenobarbitol to epileptics was present during the 
bill’s hearing and objected to some of its provisions.54  The report does not make 
clear the portions to which he objected, but the committee altered the bill upon his 
recommendation.55 
The actual text of the bill (now law) exempts prescriptions from some labeling 
requirements, but adds that those filled as part of “diagnosis by mail” are not 
exempt.56  The statute certainly does not explicitly authorize anyone to engage in 
diagnosis by mail, but instead regulates labeling requirements when diagnosis by 
mail occurs.57  A similar Iowa statute was examined by that state attorney general’s 
office in 1978, but the opinion did not address the meaning or significance of 
diagnosis by mail.58  On the other hand, one might argue that Congress clearly knew 
that diagnosis by mail was occurring (a mail-order company representative testified 
at the committee hearing), and that Congress took steps to regulate it, therefore 
Congress implicitly was sanctioning the practice.  Moreover, interstate commerce 
and mail-related commerce are the primary domain of Congress, so states arguably 
couldn’t impede what Congress had sanctioned.  On the whole, however, that 
argument seems a bit of a reach. 
An explanation of this statute would be helpful because the legal issues 
surrounding online pharmacies are so similar to those faced by mail-order 
pharmacies.  The regulation concerning diagnosis by mail implicitly concedes that 
the practice of pharmacy is not clearly divided from the practice of medicine.  
“Diagnosis by mail” indicates a physician has diagnosed a patient remotely and is 
personally filling and labeling the prescription for delivery to the patient.59  Thus 
                                                                
54Id. 
55Id. 
56Federal Food, Drug, and Cosmetic Act § 9, 21 U.S.C. § 353(b)(2) (1999).  The Act reads 
in relevant part:  
any drug dispensed by filling or refilling a written or oral prescription of a practitioner 
licensed by law to administer such drug shall be exempt from the requirements of 
section 352 of this title… if the drug bears a label containing the name and address of 
the dispenser, the serial number and date of the prescription or of its filling, the name 
of the prescriber, and, if stated in the prescription, the name of the patient, and the 
directions for use and cautionary statements, if any, contained in such prescription.  
This exemption shall not apply to any drug dispensed in the course of the conduct of a 
business of dispensing drugs pursuant to diagnosis by mail, or to a drug dispensed in 
violation of paragraph (1) of this subsection.   
Id.  (emphasis added). 
57Id. 
58Iowa Op. Att’y Gen. 548 (1978), available at 1978 WL 17419. 
59Id. (citing DeFreese v. United States, 270 F.2d 730, 734 n.7 (2d Cir. 1959)) (“It has 
always been the rule that a physician who does his own dispensing is also acting in the 
capacity of a pharmacist.”). 
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legal opinions on the interstate practice of medicine can be relevant to the interstate 
practice of pharmacy. But, as previously mentioned, no court has cited this portion of 
the statute, much less attempted to apply it, so it is difficult to determine its 
significance. 
Much of the legal uncertainty concerning interstate pharmacy arises from the 
difficulty in determining where state regulation ends and federal regulation begins.  
The Supreme Court of Iowa described an “interlocking trellis” of federal and state 
regulations governing prescription drugs, and no one seems to dispute that federal 
and state roles are intermingled.60  Federal preemption of pharmaceutical regulation 
is essentially a patchwork, with Congress expressing a clear intent to dominate some 
areas (such as the regulation of nonprescription drugs) but denying any desire to 
occupy the field generally.  Congress’ failure to explain just how much of the field it 
intended to occupy has made issues of preemption difficult to resolve. 
All authorities seem to agree that drug regulation is within the traditional police 
power of the state and that federal law reserves at least some role for the states.61  
Congress stated rather clearly, in fact, that it did not intend to preempt the states’ 
involvement in drug regulation: 
No provision of this title shall be construed as indicating an intent on the 
part of Congress to occupy the field in which that provision operates, 
including criminal penalties, to the exclusion of any State law on the same 
subject matter which would otherwise be within the authority of the State, 
unless there is a positive conflict between that provision of this title and 
that State law so that the two cannot consistently stand together. 62 
Nonetheless, courts have varied widely when asked to decide what does and does 
not constitute a “positive conflict” between state and federal laws that govern 
prescription drugs. 
The Iowa court struck down a state regulation that forbade Iowa pharmacies from 
filling prescriptions written by out-of-state practitioners, in part because the court 
believed such a rule conflicted with federal policy.63  The court relied on a 
description of the federal law’s purpose, as summarized by the U.S. Code 
Congressional and Administrative News: 
The bill is designed to improve the administration and regulation of the 
manufacturing, distribution, and dispensing of controlled substances by 
providing for a ‘closed’ system of drug distribution for legitimate handlers 
of such drugs.  Such a closed system should significantly reduce the 
widespread diversion of these drugs out of legitimate channels into the 
illicit market, while at the same time providing the legitimate drug 
industry with a unified approach to narcotic and dangerous drug control.64 
                                                                
60Iowa v. Rasmussen, 213 N.W.2d 661 (Iowa 1973).   
61See, e.g., 25 AM. JUR. 2D Drugs and Controlled Substances § 17 (1996). 
6221 U.S.C. § 903 (1999). 
63Rasmussen, 213 N.W.2d at 666.  
64U.S. Code Congressional and Administrative News, 91st Cong., 2d Sess., 1970, Vol. 3, 
at 4571-72. 
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The court seemed to conclude that out-of-state physicians who complied with the 
licensing requirements of their respective states had also met the requirements of the 
federal act; therefore, Iowa’s additional requirements impeded the effort to create a 
nationalized drug distribution system.65  In an advisory opinion, the Ohio Attorney 
General reached a similar conclusion.66 
The Texas Attorney General’s Office disagreed with the Iowa court’s conclusion 
regarding federal preemption, describing it as “no longer persuasive.”67  However, 
Texas officials cited no basis for this conclusion, but instead referred to the portion 
of the federal statute dealing with preemption: 21 U.S.C. § 903, the same portion of 
the law cited by the Iowa court.68  Thus state courts disagreed on the intended 
purpose of the act and therefore disagreed on its intended breadth – i.e., how much of 
the field was occupied if Congress did not intend to occupy the entire field.69  The 
state courts also disagreed about how much conflict constituted a “positive 
conflict.”70 
The Court of Appeals of Oregon, for example, expressly rejected the conclusion 
of the Iowa Supreme Court in Nichols v. Board of Pharmacy:  “Because the Oregon 
statute does not authorize what federal law prohibits, and because the limitation it 
imposes is consistent with the purpose of the federal statute, we believe that the two 
statutes can ‘consistently stand together’ within the meaning of 21 U.S.C. § 903.”71 
The court upheld the suspension of an Oregon pharmacist’s license because he 
filled a prescription written by an out-of-state practitioner.72  In National 
Pharmacies, Inc. v. DeMelecio, the U.S. District Court held that  Puerto Rico’s 
stringent licensing requirements were within the traditional police powers of the state 
and had not been preempted by federal law.73  The court concluded that the 
preempted portions of pharmaceutical regulation dealt only with controlled 
substances, with “controlled substances” defined as “drugs or medication which have 
the potential for abuse and which can cause dependency.”74  Other classes of 
prescription medication would not fall within that definition, the court concluded, 
therefore Puerto Rico could continue to require that all prescriptions be filled by 
pharmacists in Puerto Rico.75 
Perhaps unwittingly, the National Pharmacies court raises a strange prospect.  If 
the court was correct, one can argue that Congress intended to “federalize” 
                                                                
65Rasmussen, 213 N.W.2d at 666.   
66See Ohio Op. Att’y Gen. No. 82-032 (1982). 
67See Texas Op. Att’y Gen. No. JM-555 (1986). 
68Id.  
69Id.   
70Id.   
71657 P.2d 216 (Or. Ct. App. 1983). 
72Id.   
7351 F. Supp. 2d 45 (D.P.R. 1999). 
74Id. at 54.  
75Id.  This case seems to be an aberration, as will be discussed hereinafter. 
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regulation of some prescription drugs (“controlled substances”) but not others.76  
This is particularly true if the Rasmussen court’s interpretation of the purpose of the 
federal act – to create a national “closed system” essentially administered by the 
states – is correct.77  Thus federal law would permit a Puerto Rican pharmacist to fill 
a New Jersey physician’s prescription for a controlled substance (e.g. morphine) 
because that part of the federal regime has preempted state regulation, yet a Puerto 
Rican pharmacist could not fill an antibiotic prescription from a New Jersey 
physician because that part of the state regulations had not been preempted.  
Conversely, a resident of Puerto Rico would be able to purchase morphine from a 
nonresident Internet pharmacy but unable to purchase an antibiotic from the same 
pharmacy.  To date, no court has addressed this potential dichotomy. 
In Ferndale Laboratories, Inc. v. Cavendish, the only federal appellate case 
dealing with the role of states in interstate pharmaceutical regulation, the Sixth 
Circuit (in dicta) favored federal preemption.78  The court concluded the Prescription 
Drug Marketing Act of 1987 [hereinafter “PDMA”] granted states only the authority 
“to follow federal requirements in licensing wholesale distributors.”79  The PDMA 
had been intended to prevent dangerous drugs from escaping the wholesale 
distribution system (a sizeable market involving interstate commerce) into the black 
market.80  Accordingly, the Ferndale case dealt only with wholesale distributors,81 
though one might argue that the principle would apply to all pharmaceutical 
distributors dealing in interstate commerce.  If that is true, then one could conclude 
that states are essentially administrative agents for purposes of interstate drug 
regulation.  Some support for that argument can be found in the PDMA itself, which 
specifically authorizes state and local governments to act as agents of the federal 
government in enforcement matters.82  Accordingly, part of the argument for 
insisting that states recognize prescriptions from nonresident practitioners might rest 
indirectly on the Full Faith and Credit Clause of the Constitution, i.e. if one state 
certifies that a practitioner is authorized to act within the federal regime, then another 
state must give full faith and credit to the acts of that practitioner.  To date, no court 
has cited the Full Faith and Credit Clause as having any effect on the interstate 
regulation of pharmacies. 
V.  THE COMMERCE CLAUSE 
Several courts have wrestled with the impact of the Commerce Clause – 
specifically the “Dormant” Commerce Clause – on regulation of out-of-state 
pharmacies.  The U.S. Supreme Court set forth the general criteria for Dormant 
Commerce Clause decisions in Pike v. Bruce Church, Inc.,83 though much of the case 
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law applied to out-of-state pharmacies has been developed in the state courts or by 
state attorneys general.  The Pike Court struck down a statute which stated a primary 
purpose of promoting the reputation of Arizona cantaloupe growers by prohibiting 
deceptive packaging and requiring a certain type of packaging before out-of-state 
shipment.84  The practical result, as stipulated by the parties, was to require the 
plaintiff to build a processing plant in Arizona.85 
The Court expressed particular suspicion for regulations that required business 
operations be performed in the home state when they could be performed more 
efficiently elsewhere: 
Where the statute regulates evenhandedly to effectuate a legitimate local 
public interest, and its effects on interstate commerce are only incidental, 
it will be upheld unless the burden imposed on such commerce is clearly 
excessive in relation to the putative local benefits.  If a legitimate local 
purpose is found, then the question becomes one of degree.  And the 
extent of the burden that will be tolerated will of course depend on the 
nature of the local interest involved, and on whether it could be promoted 
as well with a lesser impact on interstate activities.86 
In a 1986 opinion for the Texas Board of Pharmacy, the state attorney general’s 
office offered a concise summary of the divergent applications of Commerce Clause 
doctrine.87  In Pharmaceutical Manufacturers Ass’n v. New Mexico Board of 
Pharmacy, for example, the court held that regulations and a licensing fee imposed 
by New Mexico on out-of-state pharmacists were reasonable compared with the 
state’s interest in drug control.88  The regulations dealt with safe storage and labeling 
of drugs and with registration or licensing of pharmacists.89  Similarly, the Wisconsin 
Attorney General concluded that the purpose of Wisconsin’s regulations was to 
protect the public and that any effect on interstate commerce was incidental.90 
In contrast, the Iowa Supreme Court struck down regulations that effectively 
prohibited Iowa pharmacists from filling prescriptions written by nonresident 
physicians who were not registered with Iowa authorities.91  As noted previously, the 
Iowa court struck down the regulation in part because (the court believed) the state 
regulations conflicted with federal drug control law.92  But the court also concluded 
the regulation was an unnecessary barrier to interstate commerce.93  The Nebraska 
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and Ohio Attorneys General similarly concluded that their state’s regulatory schemes 
were unconstitutional.94  All the authorities agreed that regulation of prescription 
drugs meets the first part of the Commerce Clause test, namely that the regulation 
must effect a legitimate local interest.  However, under the Pike standard, a 
regulation that does not discriminate against out-of-state commerce on its face can 
nonetheless violate the Dormant Commerce Clause if its application burdens 
interstate commerce beyond the benefits the state derives from the regulation.95  This 
latter determination – what constitutes an unreasonable burden – is a mixture of fact 
and law that usually is left for the courts to resolve. 
One could argue that the Dormant Commerce Clause is now more relevant than 
ever to telemedicine because the standards of practice are, in effect, national 
standards.96 
Although administrative practices might vary from state to state, in the 
past 30 years there has been a remarkable convergence in licensing 
requirements stipulated by states to license physicians.  All states require 
the United States Medical Licensing Examination (USMLE).  All 
recognize appropriate credentials from nationally accredited medical 
schools and residency programs regardless of location.  All specialty 
board certification is conferred by national organizations and are based on 
national standards….  In fact, there is little, if any data to support the 
claim that physicians of one state are more or less qualified than those of 
any other state.97 
This is all the more true of pharmacy, which has long been subject to uniform 
federal standards.  While states regulate practitioners, the federal government has 
long had an active role in governing the content of drugs, the labeling of 
prescriptions, and even the advertising of prescription and non-prescription drugs.  
Accordingly, online pharmacies can argue that the states’ interest in asserting their 
police powers against out-of-state pharmacies is moot. 
Not surprisingly, different jurisdictions reach different conclusions. For its part, 
the Texas Attorney General’s Office advised the state pharmacy board that any rules 
it adopted should be “the least burdensome regulation which well effect the state’s 
objectives” in order to comply with the Commerce Clause.98  Most courts seem to 
agree with this proposition.99  Texas officials also concluded the board “may regulate 
out-of-state mail-order pharmacists only to the extent that they actually engage in the 
practice of pharmacy or dispense, deliver, or distribute prescription drugs within the 
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state of Texas,” i.e. the Texas board could not physically inspect nonresident 
facilities that shipped prescriptions into Texas.100 
Recent cases seem to support those views.  As noted before, the Sixth Circuit 
concluded that the PDMA of 1987 granted states only the authority “to follow 
federal requirements in licensing wholesale distributors.”101  The case dealt only with 
wholesale distributors,102 and wholesale distributors (as opposed to retailers) 
presumably would not have nearly the impact on the consumers of other states.  But 
even in this context, the court concluded it was not unreasonable for Ohio to require 
a Michigan distributor to pay a $100 annual registration fee and to keep a record of 
the drugs it shipped into Ohio.103  At the very least, states will likely be able to 
require registration and production of records that relate to the receiving state.  This 
is particularly important if the VIPPS program (discussed previously) of the NABP 
is to be successful. 
But the Sixth Circuit apparently did not persuade the U.S. District Court for the 
District of Puerto Rico.  The National Pharmacies court upheld rather stringent local 
regulations that substantially affect interstate commerce.104  The local regulations 
establish strict requirements for the practice of pharmacy that effectively prevent any 
pharmacy/pharmacist outside Puerto Rico from filling prescriptions for Puerto Rico 
residents.105 
In all cases where a pharmacist is practicing his profession, he shall be a member 
of the College of Pharmacists of Puerto Rico,106 of age, shall manage in person the 
establishment under his supervision, and shall reside in the town in which he is 
practicing.107 
Section 402 requires that every pharmacy be managed by a pharmacist authorized 
to practice in Puerto Rico.108  That section even limits the number of hours per week 
that the pharmacist may be absent from the pharmacy.109 
The National Pharmacies case arose when Blue Cross of Puerto Rico entered a 
contract with National Pharmacies, Inc. of New Jersey for mail-order drug delivery 
to Blue Cross customers in Puerto Rico.110  The Puerto Rican government sought to 
ban National from serving customers in Puerto Rico because it was located in New 
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Jersey and it and its pharmacists did not meet the requirements of Puerto Rican 
law.111  In siding with the government, the court concluded Puerto Rican law was not 
preempted by federal drug law (as discussed previously).112  The court also held that 
Puerto Rican law did not violate the Dormant Commerce Clause.113  This latter 
holding seems particularly difficult to reconcile with prior case law, particularly 
Pike: 
For the Court has viewed with particular suspicion state statutes requiring 
business operations to be performed in the home State that could more 
efficiently be performed elsewhere.  Even where the State is pursuing a 
clearly legitimate local interest, this particular burden on commerce has 
been declared to be virtually per se illegal.114 
Interestingly, the National Pharmacies court cites none of the cases cited thus far 
except Ferndale, and it cites that case only with reference to the police powers of 
Puerto Rico.115  The plaintiffs seem to have had strong grounds for an appeal though 
apparently none was filed. 
VI.  LIMITS TO REGULATION 
Whatever laws the states or federal government adopt, the practical barriers to 
regulation are enormous.  First and foremost, regulators in the United States are 
dealing with pharmacies that can appear on the Internet without warning and then 
disappear overnight.  Even if regulators can figure out the location of the host 
computer, they still may not know the state – or country – in which the drugs are 
stored and dispensed.  In the unusual event regulators close an online pharmacy, the 
owners can reopen under another name, through another corporation, and/or from a 
different location.  Federal regulators acknowledge the seemingly insurmountable 
obstacles,116 but are nonetheless asking for an additional $10 million to hire new 
personnel to regulate online pharmacies.117  Interestingly, former President Clinton’s 
fellow Democrats questioned whether the Administration really knew what it 
needed, or whether it arrived at the $10 million figure arbitrarily.118 
VII.  FOREIGN PHARMACIES 
Pharmaceuticals frequently cost far less outside the U.S. market, even when the 
drug is the same and is manufactured by the same company.119  To dramatize the 
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difference between U.S. and foreign drug prices, Congressman Bernard Sanders 
accompanied six senior citizens from Vermont to a Montreal pharmacy in July 1999; 
one woman in the group paid $12.08 for sixty tamoxifen pills (used to treat breast 
cancer), but she would have paid more than $100 for that amount in the United 
States.120  Internet entrepreneurs have used these price differences to their advantage.  
For a $10.95 monthly subscription to the BDZI Pharmacy Watch Web site, the 
company provides access to pharmacies worldwide and advice on getting the drugs 
into the United States.121  “Access to Mexican, Foreign and American Doctors from 
our web site that will write you prescriptions, if needed,” claims the site.122  One 
group that favors deregulating prescription drugs publishes on its Web site a 
comparison of brand-name drugs in Europe that cost as little as one-tenth the price of 
the same drug in the United States.123  On the other hand, proponents of regulation 
argue that products available in some countries, particularly Mexico, may be of 
inferior quality or may be held for retail sale in sub-optimal conditions.124 
Whether good or bad, the fact remains that the drugs are imported.  Furthermore, 
if online pharmacies in the United States seem difficult to regulate, they are hardly as 
unregulated as online pharmacies in other countries.  Most countries, including those 
of the European Union, have always been far less stringent regulators of prescription 
drugs than the United States.125  Many drugs available only by prescription in the 
U.S. can be purchased over the counter elsewhere, so it should come as no surprise 
that many pharmacies in those countries put forth little effort (if any) to insure U.S. 
patients have a prescription.126 
Thus foreign pharmacies present all the practical regulatory hurdles of any other 
online pharmacy, plus additional jurisdictional and legal obstacles.  On the practical 
side, Internet entrepreneurs in Europe have been sending marijuana seeds to the 
United States via mail for years, and the same methods are readily transferable to 
online pharmacies outside the United States.127  The seller may be located in a 
country that does not cooperate with U.S. enforcement efforts or, if not, the seller 
may store its server and customer information in a third country.  A secure online 
transaction can protect a purchaser in the United States from government detection, 
and the seller simply ships the illicit item in a nondescript container with no return 
address or a bogus return address.  Some pharmacies in Mexican border towns even 
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offer packaging of illegal drugs in tamper-proof sealed aspirin bottles to allay the 
suspicions of Customs officials.128  Undoubtedly these techniques have been adopted 
by online pharmacies as well. 
Free-trade treaties may also pose problems for regulators, particularly the North 
American Free Trade Agreement [hereinafter “NAFTA”].  Though NAFTA 
generally does not preclude federal public health regulations, including prescription 
drug regulations, it does nonetheless preclude state governments from enacting 
regulations on Mexican and Canadian imports, i.e. only the federal government can 
regulate imports from a NAFTA partner.129  No state government has yet tried to act 
against a pharmacy in Mexico or Canada, but any such effort would almost certainly 
fail even if an injunction were sought in federal court.  The state laws enforced by 
the Kansas, Missouri, and Illinois courts on pharmacies in other states would 
presumably be preempted by NAFTA if the courts sought to apply them to a 
pharmacy in Mexico or Canada. 
On the other hand, one could argue that states are entitled to act against imports 
from a Mexican or Canadian pharmacy via the FDC, which specifically authorizes 
state and local governments to act as agents in enforcing federal drug laws.130  
Accordingly, a state attorney general might have standing to bring a claim in federal 
court under federal drug control laws against a Mexican or Canadian pharmacy 
because the state official is acting in a federal capacity.  The state might argue that 
the practitioners and pharmacies outside the U.S. are not licensed within the meaning 
of the FDC because it implicitly referred to professional licenses granted by the 
States.  That argument has not been confronted, much less resolved, by U.S. courts.  
In any event, state governments appear to have more authority to prevent imports 
from other states than from Canada or Mexico. 
This begs the question why any state official should want to regulate online 
pharmacies in the first place.  Internet commerce is unique in that the smallest 
vendor immediately becomes a nationwide and perhaps worldwide vendor.  
Enforcement incentives are altered dramatically because geography loses its 
relevance.  Prior to e-commerce, a rogue pharmacist and his customers probably 
were all within driving distance of the pharmacy.  Thus the harm was almost 
exclusively local, and local regulators had incentive to act.  Conversely, the online 
pharmacy that sells Viagra to teenagers in Kansas will also sell Viagra to teenagers 
in the other forty-nine states.  Kansas can argue that it should not have to shoulder 
the responsibility of what is in essence a national threat to public health.  In fact, the 
Texas Board of Pharmacy has made that very argument: “We just don’t have the 
personnel to spend a long time on the Internet searching for [rogue pharmacies],” 
said Gay Dodson, executive director of the Texas Board of Pharmacy.  She 
continued, “we… could go out and look every day to see what’s out there, but sites 
pop up just overnight.”131  Her ten investigators handled 1500 complaints in 1998, 
                                                                
128Reza, supra note 126. 
129Noah, supra note 124, at 155. 
130Federal Food, Drug, and Cosmetic Act § 9, 21 U.S.C. § 372(a) (1999). 
131Andrew Park, FDA May Help States Regulate Web-based Pharmacies, KNIGHT-RIDDER 
TRIB. BUS. NEWS, Dec. 29, 1999, available at 1999 WL 28721498. 
182 JOURNAL OF LAW AND HEALTH [Vol. 15:165 
and another five employees were responsible for inspecting the state’s 5000 
pharmacies.132 
Aside from lower prices, foreign online pharmacies hold another advantage over 
online pharmacies in the United States.  At the height of the AIDS scare in the late 
1980’s, AIDS activists demanded immediate access to potential treatments that were 
available overseas but not in the United States.133  A July 20, 1988, FDA memo 
opened the door to these imports.134  Importing drugs unapproved by the FDA was 
(and still is) flatly prohibited by law, but the FDA used its enforcement discretion to 
allow U.S. consumers to import up to ninety days’ worth of drugs for personal use.135  
The policy is designed to allow U.S. residents to purchase drugs not approved by the 
FDA if (1) the patient is using the drug under the care of a physician and (2) the drug 
is not available in the United States.136  The latter stipulation is more significant than 
it may appear – according to the policy, patients cannot purchase a drug that is 
available in the United States, e.g. a U.S. patient could not purchase Prozac from a 
foreign pharmacy because Prozac is available in the United States.137  In practical 
terms, this policy prevents U.S. customers from bypassing the U.S. retail drug 
market in favor of much lower retail prices in other countries. 
However, there are exceptions to the exception.  A U.S. resident can purchase a 
drug from a foreign pharmacy even if that drug is available from U.S. pharmacies, 
but only if the FDA has certified and approved the manufacturing source (a single 
drug such as Prozac may be manufactured in different locations for different 
markets).138  And there is an exception to the limitation of the exception: even if the 
FDA has not approved the manufacturing source, FDA enforcement standards allow 
the drug to be delivered to the U.S. customer with a simple warning that the FDA 
cannot vouch for the safety of the product.139  In other words, it is possible to buy 
almost any drug from a foreign pharmacy, regardless of whether it is available in the 
U.S. and regardless of whether the FDA approved the manufacturing source, so long 
as the enforcement agent is willing to exercise his or her discretion.  And FDA 
guidelines encourage enforcement agents to do just that:  “We must remember the 
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consumer protection provided by unlimited, extensive coverage of mail imports is 
not commensurate with the resources that are expended,”140 and “[g]enerally, little 
time should be spent on the coverage of mail importations.”141 
However popular the end result may be with AIDS activists, this discretionary 
enforcement strategy presents the same problems as any other discretionary 
enforcement strategy.  First and foremost, discretionary enforcement creates legal 
and regulatory uncertainty and is ripe for favoritism or abuse.  Though there is no 
evidence of favoritism or abuse in enforcing drug import laws, the evidence of legal 
and regulatory uncertainty is compelling.  By its own admission, the extent to which 
drug import laws had been enforced by the FDA varied widely between the different 
regions and field offices.142  One memo suggests some Customs enforcement districts 
detain all imported prescription drugs, while other districts detain none: “Surveys 
have shown a significant variance among the districts in the area.  A typical example 
is the district’s coverage of mail importations which varies from 0% to 100%.  Such 
unequal enforcement is unfair to both the consuming public and the trade.”143  If the 
FDA’s own regulators and enforcement officials could not agree on what should and 
should not be cleared for delivery, one can hardly expect patients and suppliers to 
know what can or cannot be shipped.  Though the FDA memo was intended to clear 
up this confusion, it is not clear whether the memorandum made the level of 
enforcement any more uniform among the different FDA regions and field offices. 
VIII.  POSSIBLE SOLUTIONS 
While states have traditionally resisted federal incursion into professional 
licensing, online pharmacies could force the federalization (at least partially) of both 
medical and pharmaceutical licensing.  NAFTA alone could force the federal 
government to expand its role because states will be largely powerless to enforce 
their own laws against Canadian and Mexican pharmacies. 
Expanding federal regulation into an area traditionally overseen by the states 
certainly is not without precedent, and expansion of the federal role hasn’t 
necessarily meant the federal government occupied the field or even assumed direct 
control over licensing.  A relevant example is the Commercial Motor Vehicle Safety 
Act of 1986, which set minimum standards for commercial tractor-trailer and bus 
drivers.144  Prior to the Act, state licensing standards varied widely, and commercial 
drivers frequently obtained licenses from more than one state.145  Drivers could hide 
or spread convictions among several driving records and continue driving.146  The 
CMVSA allowed states to continue issuing drivers licenses, but it required them to 
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observe minimum national standards when licensing commercial drivers, and it 
forbade drivers from having a license in more than one state.147   
Likewise, federal regulation of medical practice may not be too far a leap from 
the current scheme.  The federal government is already involved in monitoring 
medical practitioners, even though states still license all healthcare professionals.148  
The U.S. Department of Health and Human Services maintains the National 
Practitioner Data Bank to keep track of complaints against physicians, and some 
members of Congress want to open the database to the public.149 
According to the American Telemedicine Association [hereinafter “ATA”], three 
basic approaches have been offered for regulating telemedicine:150 
1) Full and Unrestricted Licensure:  Each telemedicine practitioner would need 
a license in any state in which he/she consulted a patient via the Internet.  
States would decide issues of reciprocity in a way similar to the drivers 
license compact between the states, if they chose to allow reciprocity at all. 
2) Limited Licensure:  Practitioners would be licensed in the states in which 
they treat patients face-to-face, and a secondary or limited license would be 
granted for practice via telemedicine.  The secondary license could be 
granted by the states individually or by the federal government. 
3) National Licensure:  The federal government would assume control over all 
practitioner licensing.151 
The ATA supports limited licensure, as does the Federation of State Medical 
Boards [hereinafter “FSMB”].152  The FSMB produced “A Model Act to Regulate 
Practice of Telemedicine or Medicine by Other Means Across State Lines,” which 
would establish the secondary license state-by-state.153  As of May 21, 1999, only 
three states (Alabama, Tennessee, and Texas) had adopted legislation consistent with 
the Model Act.154  Conversely, fourteen states had adopted legislation requiring full 
and unrestricted licensure in the previous four years.155 
Regardless of lawmakers’ wishes, prescription drug regulation will most likely 
move from a licensing model to a certification model.  Practical considerations make 
this inevitable because, aside from expanding the “war on drugs” to prescription 
pharmaceuticals, there is little the federal government can do to prevent U.S. 
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consumers from ordering the drugs they want from a foreign pharmacy.156  To some 
extent, federal officials have acknowledged as much.157 
Yet concerns about consumer protection and public health and safety are not 
diminished with the advent of online pharmacies.  On the contrary, one might argue 
that these concerns are magnified.  As previously discussed, enforcing regulations in 
cyberspace can be difficult under the best of circumstances; online pharmacies can 
appear and disappear overnight.  Tort recovery is highly unlikely if the pharmacy is 
located in another country.  Accordingly, regulators are forced to rely on 
professional certification rather than licensure.  Programs like VIPPS could be, 
perhaps, expanded to an international scale.  Moreover, national certifications would 
acquire brand name value.  Most U.S. consumers probably wouldn’t purchase an 
unknown cancer treatment manufactured and sold in Nigeria, but U.S. consumers 
already have already demonstrated their willingness to buy pharmaceuticals from 
European sources.158  That can most likely be attributed to confidence in European 
drug regulation. 
IX.  BENEFITS TO CONSUMERS 
At the least, one can argue that the result of imports from foreign online 
pharmacies is egalitarian – no longer must a U.S. resident live near the border or fly 
to Europe for drugs that are unavailable in the U.S.  The competitive pressures of 
international retail drug trade could lower drug costs for consumers worldwide.  In 
fact, the competition is already under way.  The National Community Pharmacists 
Association is pressing Congress to allow retailers to buy drugs overseas – where 
prices are a fraction of the amount charged in the U.S. – for reimport into the United 
States.159  If the FDA maintains a fairly liberal import policy, the “brand name” value 
of each nation’s certification could result in a sort of competition between regulatory 
agencies.  For example, if U.S. consumers decide the FDA’s drug approval process 
takes too long and is unnecessarily stringent, they may decide instead to trust the 
somewhat less-stringent approval process of a European country and purchase a drug 
that is already approved in Europe but not in the U.S.  In fact, the growing business 
of importing drugs not available in U.S. pharmacies seems to indicate consumers 
have done just that.  Thus regulatory drug approval might become more like an 
Underwriter’s Laboratories listing: consumers would decide for themselves whether 
FDA approval was worth the wait (and manufacturers might debate whether it was 
worth the cost) when another country has already approved the drug.  Critics might 
argue the option to purchase desired drugs from foreign pharmacies could result in 
competitive pressures on the FDA, which in turn might shortcut its evaluation 
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process to keep pace with European agencies.  On the other hand, manufacturers 
might argue that the competitive pressure could force the FDA to strike a better 
balance between consumer protection and consumer demand.  Understandably, the 
FDA may not wish to throw the borders open to just any pharmaceutical import, but 
the emergence of international manufacturing standards should give the FDA a better 
idea of which countries provide reasonable guarantees of safety and which do not. 
X.  AN UNKNOWN 
As stated before, one would presume that the practice of medicine – including the 
aspects that relate to prescription drugs – should be the same regardless of the state.  
However, this presumption is not completely true.  Oregon, for example, licenses 
naturopathic160 doctors to prescribe under the FDC, a practice that has produced 
considerable criticism from other practitioners.161  Other states might object that they 
do not consider naturopaths adequately trained to prescribe drugs, and that under no 
circumstances would they want an out-of-state naturopath prescribing drugs to an in-
state resident.  Presumably, a state could authorize chiropractors or even pharmacists 
to prescribe drugs.  In fact, some twenty-eight U.S. states allow pharmacists limited 
authority to consult with patients, write prescriptions, and fill the prescriptions they 
write.162  But powerful physician’s associations such as the American Medical 
Association almost certainly would fight any attempt to give full prescribing powers 
to pharmacists (or chiropractors), and it is unlikely that any state government would 
extend such authority to pharmacists. 
However, the issue may not be so straightforward with American Indian tribes.  
Courts are increasingly recognizing tribal sovereignty to include almost all areas of 
civil regulation.163  Tribal governments exert authority over wildlife,164 
environmental affairs,165 and family law,166 and now some tribes are expanding their 
reach into gambling,167 corporation law,168 and even automobile licensing.169  
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Medical practice is hardly booming on Indian lands.  Physicians generally are 
provided by the U.S. Indian Health Service,170 so the adoption of professional 
medical/pharmaceutical regulation is unlikely to be guided by a politically prominent 
organization tantamount to a state or national medical association.  On the other 
hand, health care could become a major industry on tribal lands if online pharmacies 
move there to take advantage of more favorable regulations.  A tribe might, for 
example, permit pharmacists to write prescriptions themselves and to do it on the 
basis of an online form or interview.  While it is clear that the FDC gives states 
substantial latitude to determine who is or is not qualified to write prescriptions, the 
FDC makes no mention of tribal governments, much less whether they can license 
professionals to act within the FDC.171 
Tribal pharmacy regulation has not been an issue because most pharmacists who 
work on Indian lands are federal employees, and those who are not federal 
employees (as well as those who are federal employees) are licensed by a state 
pharmaceutical board (even if it is not the state in which the tribal lands are 
located).172  The states can exert some authority over the pharmacists they license, 
even when those pharmacists practice on Indian land.173  However, the states have no 
authority to regulate or inspect the facilities of pharmacies on Indian land.174 
The unanswered question is what rights – if any – the pharmacies and 
pharmacists licensed by a tribe would have beyond tribal lands.  As previously noted, 
the courts haven’t yet resolved the impact of the Dormant Commerce Clause on state 
regulation of online pharmacies.  The FDC makes no mention of tribal governments, 
but since Congress maintains sole authority to regulate commerce with Indian tribes, 
one could argue that tribal drug regulations would be subject to the same analysis as 
state drug regulations.  Internet commerce in general presents promising 
opportunities for economic growth on reservations, many of which are isolated from 
major population centers.  Because of the unique legal authority of tribal 
governments and the near irrelevance of geography in Internet commerce, Indian 
territory may prove to be a popular location for online pharmacies.  If so, Congress 
will be faced with yet another challenge to traditional drug regulation. 
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